News

High channel count EEG recommended as a quality standard for presurgical epilepsy workup. The working group on presurgical epilepsy diagnosis and operative epilepsy treatment has published their guidelines for quality standards for Austria, Germany, and Switzerland. The standards include video EEG with at least 64 channels and at least two other advanced imaging methods, including 64-256 channel EEG with source imaging. Access the paper.

UBC researchers develop test for concussion using dense array EEG. Researchers at the University of British Columbia are using EGI’s dense array EEG as an objective method of assessing brain changes after a concussion. Watch the 3-minute video that describes this exciting research.

EGI Science team publishes seminal paper on new Geodesic Transcranial Electrical Neuromodulation (GTEN) Technology. In this first study of GTEN technology, EGI investigates the effects of precision, dense array neuromodulation on specific brain targets. Pulsed protocols showed long-term depression of motor cortex excitability, sustained over 90 minutes following current injection. Read the paper. Read more about EGI’s GTEN 100 Research product.

Workshops, Schools, and Symposia

EGI Symposia ON DEMAND
Dense Array Transcranial Electrical Neuromodulation. Details. View it now.

Conferences

Clinical Conferences
Research Conferences

research products button clinical products button

customer publication buttons clinical application button current manuals button

GTEN imageEGI introduces new GTEN 100 neuromodulation

Revealed at the Organization for Human Brain Mapping meeting in Geneva, EGI’s new GTEN 100 System is the most sophisticated non-invasive neuromodulation system on the market, introducing a new level of rigor and precision to this important field of research. EGI’s new GTEN 100 Neuromodulation System includes the ability to choose from 256 electrodes for tDCS, tACS, and tPCS neuromodulation with simultaneous EEG. Planning and targeting software incorporates high-definition electric head models, based on individual MRI scans if desired, for the highest level of precision. Available now for research use.
Read the news article. GTEN web page. Contact EGI for more information.

Read about the science behind GeoSource 3.0 source imaging and GTEN 100 neuromodulation.

NEW! View EGI's GTEN Symposium presented at OHBM 2016. See it now with EGI Symposia ON DEMAND. 

NEW! EGI's new study using GTEN 100 Research System and pulsed protocols showed long-term depression of motor cortex excitability, sustained over 90 minutes following current injection. Read the paper.

About EGI

EGI is a medical device company that designs, develops and commercialises a range of non-invasive neurodiagnostic products used to monitor and interpret brain activity. A key component of these products is EGI’s proprietary dense array electroencephalography (dEEG) platform technology. The dense array method gathers brain activity data from many more electrodes than conventional EEG products (up to 256), generating significantly higher quality and more precise levels of information. With regulatory clearance in the US, EU and a number of other major international regulatory bodies, the Company’s technology has been increasingly adopted as a powerful research tool and more recently as a cost effective and patient friendly clinical neurodiagnostic platform.

advamed sm logo